Indication
Prophylaxis of influenza in individuals 24 months to less than 18 years of age. The use of Fluenz should be based on official recommendations.
Loading your page…
Loading your page…
Influenza, Human;Immunization
Marketing Authorisation Holder: MedImmune LLC
EMA Authorisation: 27/01/2011
INN: influenza vaccine (live attenuated, nasal)
AI Drug & Interaction Analysis
Free account required
Ask Osler about Fluenz: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.